Navigation Links
Breast Cancer Patients Experience a Faster Return to Normal Life
Date:10/8/2008

, Virginia Hospital Center is the only medical facility in Northern Virginia offering this cutting-edge procedure. The procedure is used exclusively in women who have undergone breast conservation therapy (lumpectomy) as opposed to mastectomy. To qualify for APBI, candidates must be 45 years or older with a single, small tumor (less than 3 cm in diameter), no evidence of metastasis, and a tumor cavity that is surrounded by a good margin of healthy tissue.

Women with multiple tumors or cancers that have extended into the lymph nodes are more likely to benefit from standard whole breast external beam radiation, which delivers a uniform dose to the entire affected area following mastectomy or lumpectomy. This approach may be used in combination with intensity modulated radiation therapy (IMRT), which subsequently delivers targeted higher doses of radiation to known "hot spots" in the breast.

A current national clinical trial is investigating potential future applications of APBI in younger women, for the treatment of multiple tumors, and cases where cancer has spread to the lymph nodes.

About Virginia Hospital Center:

For over 60 years, Virginia Hospital Center has provided exceptional medical services to the Washington metropolitan area. Virginia Hospital Center's new $150 million state-of-the-art facility offers comprehensive healthcare and multiple Centers of Excellence including Cardiology & Cardiovascular Surgery, Neuroscience, Oncology, Women & Infant Health and Urology. Growing service lines include Executive Health and the only Lung Cancer Center in Northern Virginia. Virginia Hospital Center is a teaching hospital, long-associated with Georgetown University's School of Medicine, and accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and Licensed by the Commonwealth of Virginia Department of Health. For additional information, please visit

SOURCE Virginia Hospital Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... the number of Americans living with diabetes will...09 to 44.1 million in 2034. Over the same period, ...om $113 billion to $336 billion, even with no incr...ed at the University of Chicago report in the Dece...hose with diabetes covered by Medicare will rise f...
(Date:11/26/2009)...l when on an emotional rollercoaster, study finds ...- Call it the fear factor meets the jubilant sport...- especially those who root for the winning team -...y contested match and victory was in doubt, produc...on that this Thanksgiving weekend as you,re glued ...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leading ...oday announced the expansion of its services to in...r. Doug Macmillan. , D...leased to announce that Dr. Doug Macmillan, an exp...n additional advanced training seminar. RTDental&...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--Whenmostpeoplehearthea...canalsogivepatientsthehelptheyneed.TMJstandsforthe...ble)contacts/connectswithyourskull(temporalbone). ...ctionarepainwithchewing,clickingorpoppingofthejaw....ncluding:headaches,fatigue,sleepdisturbances,irrit...
(Date:11/25/2009)...RY,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...andsoftwareandCalgaryScientificInc.,aleadingprovid...bversionofAegis(TM)Breast4DAdvancedVisualizationso...lyzero-footprintWebclientbasedmedicalimagingofferi...rmallowsforzero-footprintaccess-requiringnosoftwar...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... come together on West Coast for a free educationa...eir families, SAN DIEGO, CA, Sept. 15 /PRNewswire...are diagnosed with a primary or metastatic brain t...,Tumor Foundation (NBTF) partnered with BrainLAB a...
...serious underlying health trouble, experts say , ...ile the occasional stomachache isn,t a serious hea...other matter that could signal serious trouble, sa...rring pain; , pain lasting for hours or days; , pa...
...upports angioplasty, but not everyone agrees , ...versy still swirls around how doctors can best tre...na, with some physicians favoring the use of drugs...n (COURAGE), seemed to indicate that drug therapy ...
... The Center of Excellence in Environmental Toxicol...l of Medicine has been awarded $2.3,million over t...of,exposure to cigarette smoke. The grant is part ...s and,environmental health scientists. In this fir...
...Leader of the Global Breast Cancer Movement, Takes...LLAS, Sept. 14 The appointment of Ambassador Nanc...re, the world,s largest breast,cancer organization...ally begin work Monday. A ceremonial swearing in,i...
... BIRMINGHAM, Ala., Sept. 14 /PRNewswire-USNewswire... now offering a specialized,professional liability...ls.,The coverage is being made available through P...,s community,based hospitals with our proven, cost...
Other Medicine News:Health News:National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education 2Health News:National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education 3Health News:Doctors Debate Drugs vs. Surgery for Angina 2Health News:Doctors Debate Drugs vs. Surgery for Angina 3Health News:Doctors Debate Drugs vs. Surgery for Angina 4Health News:Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure 2Health News:Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure 3Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 2Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 3Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 4Health News:ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan 2
(Date:11/25/2009)...ass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartW...inginnovatorandprovideroflessinvasive,miniaturized...eatmentofadvancedheartfailure,todayannouncedthatit...nualPiperJaffrayHealthCareConferenceat8:00amESTonW...theNewYorkPalaceHotel,December1-2. ,, Alivewebc...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nas...foraorticdisorders,announcedtodaythatithasfiledamo...infringementlawsuitbroughtagainstitinOctober2009by...tCourtinIndianapolis,Indiana. ,, Endologixhasre...esPatentandTrademarkOffice(USPTO)conductsproceedin...
(Date:11/24/2009)...E,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.an...nistration(FDA)hasacceptedforreviewEisai,sNewDrugA...ezilHClextendedrelease)tabletsforthetreatmentofmod...oseformulationcontains23mgofdonepezilHClinanextend...allowsforgradualreleaseofthedrug.TheNDAisbasedonah...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Prolonged Use of Pacifier Linked to Speech Problems 59896 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2
... aimed at reducing cross contamination ...E, Fla., Oct. 18 Seal Shield Corporation,announce...l products for,infection control. Notably, Seal Sh... Washable Keyboard and Mouse. According to the com...he first ever antibacterial,keyboard and mouse to ...
...ssion, ATRIPLA Would Represent the, First and Only...S Patients in the European ... WHITEHOUSE STATION, N.J., Oct.,18 Bristol-Myers ... (Nasdaq: GILD ) and Merck & Co., Inc. (NYSE: MR...al Products for Human Use,(CHMP) of the European M...
Other Medicine Technology:Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 2Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10
MBP 200GGenomic Tip
MBP 300E Multi-Channel
LH EIA kit
Luteinizing Hormone (LH) Enzyme Immunoassay Test Kit
Medicine Products: